Single‐dose pharmacokinetic study comparing the pharmacokinetics of recombinant human chorionic gonadotropin in healthy Japanese and Caucasian women and recombinant human chorionic gonadotropin and urinary human chorionic gonadotropin in healthy Japanese women
Abstract Purpose Recombinant hCG (r‐hCG) was approved in Japan in 2016. As a prerequisite for a Phase III study in Japan related to this approval, the pharmacokinetic (PK) profile of r‐hCG was investigated. Methods An open‐label, partly randomized, single‐center, single‐dose, group‐comparison, Phase...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Reproductive Medicine and Biology |
Subjects: | |
Online Access: | https://doi.org/10.1002/rmb2.12066 |